Cliff Asness’s DermTech, Inc. Common Stock DMTK Stock Holding History

Cliff Asness’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-174,628	Closed	-$309K	–	2278
2022 Q4	$309K	Buy	174,628 +156,523	+865%	+$416K	﹤0.01%	1962
2022 Q3	$72K	Buy	+18,105	New	+$111K	﹤0.01%	2128
2021 Q4	–	Sell	-8,093	Closed	-$260K	–	2304
2021 Q3	$260K	Buy	8,093 +1,619	+25%	+$56.9K	﹤0.01%	2078
2021 Q2	$269K	Buy	+6,474	New	+$266K	﹤0.01%	2073

Other funds holding DMTK

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Cliff Asness's DMTK Position: Q1 2023 in Review

Cliff Asness sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2023, closing a stake of 174,628 shares — an estimated $309K sold.

Cliff Asness first reported a position in DMTK in Q2 2021 and held it in 4 quarters. The position peaked at $309K in Q4 2022. 99 funds tracked by Wall St. Rank hold DMTK as of Q1 2023.

Cliff Asness reported no remaining DermTech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Cliff Asness sold 174,628 DermTech, Inc. Common Stock shares in Q1 2023, an estimated $309K.
Cliff Asness first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Cliff Asness's DermTech, Inc. Common Stock position peaked at $309K in Q4 2022.
99 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2023.

Based on AQR Capital Management's 13F filing for Q1 2023, filed 15 May 2023.